{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:33:49Z","timestamp":1791232429715,"version":"4.1.0"},"reference-count":104,"publisher":"Archives of Pathology and Laboratory Medicine","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    <jats:italic>Context<\/jats:italic>\n                    .\u2014Interleukins (ILs) 6, 10, and 13 seem to be important in the pathogenesis of Hodgkin lymphoma (HL), but there is insufficient data on the serum levels of these cytokines in patients with HL.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:italic>Objectives<\/jats:italic>\n                    .\u2014To evaluate serum levels of IL-6, IL-10, and IL-13 before and after HL treatment and to determine their potential association with clinical and laboratory parameters.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:italic>Design<\/jats:italic>\n                    .\u2014Serum IL-6, IL-10, and IL-13 levels were quantified in the serum of 27 patients with HL by enzyme-linked immunosorbent assay. Results were evaluated against clinical and laboratory parameters, response to treatment, and presence of infection by the Epstein-Barr virus. As a control group, serum samples from 26 healthy blood donors were evaluated the same way.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:italic>Results<\/jats:italic>\n                    .\u2014Pretreatment serum levels of IL-6 and IL-10 were significantly higher in patients with HL (\n                    <jats:italic>P<\/jats:italic>\n                    &lt; .001), and a significant decrease was observed after treatment (\n                    <jats:italic>P<\/jats:italic>\n                    &lt; .001). Serum IL-13 was undetectable in both patient and control groups. Serum IL-6 was higher in patients with abdominal involvement (\n                    <jats:italic>P<\/jats:italic>\n                    \u200a=\u200a .02), hepatomegaly (\n                    <jats:italic>P<\/jats:italic>\n                    \u200a=\u200a .03), B symptoms (\n                    <jats:italic>P<\/jats:italic>\n                    \u200a=\u200a .02), and anemia (\n                    <jats:italic>P<\/jats:italic>\n                    \u200a=\u200a .02). Serum IL-10 levels were higher in patients with hypoalbuminemia (\n                    <jats:italic>P<\/jats:italic>\n                    \u200a=\u200a .04). No association with EBV status was observed. Lymphocytopenia and B symptoms were accurate predictors of IL-6 serum levels before treatment, and higher pretreatment levels of IL-6 were observed in patients with treatment failure (\n                    <jats:italic>P<\/jats:italic>\n                    \u200a=\u200a .03).\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:italic>Conclusions<\/jats:italic>\n                    .\u2014Serum levels of IL-6 and IL-10 were frequently elevated in patients with HL and decreased substantially after conventional chemotherapy. The association of elevated IL-6 and IL-10 levels in serum with some clinical and laboratory features suggests those ILs may be useful biomarkers for monitoring the HL disease and its response to chemotherapy.\n                  <\/jats:p>","DOI":"10.5858\/2010-0060-oa.1","type":"journal-article","created":{"date-parts":[[2021,2,12]],"date-time":"2021-02-12T13:17:45Z","timestamp":1613135865000},"page":"483-489","source":"Crossref","is-referenced-by-count":33,"title":["Serum Levels of Interleukins 6, 10, and 13 Before and After Treatment of Classic Hodgkin Lymphoma"],"prefix":"10.5858","volume":"135","author":[{"given":"Rafael D","family":"Gaiolla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria A. C","family":"Domingues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00edgia","family":"Ni\u00e9ro-Melo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deilson Elgui","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3906","reference":[{"issue":"5","key":"i1543-2165-135-4-483-b01","series-title":"Curr Opin Oncol","first-page":"432","article-title":"Treatment of early-stage nonbulky Hodgkin lymphoma","volume":"18","author":"Straus\n              DJ.","year":"2006","unstructured":"Straus\n              DJ. \n          \n          Treatment of early-stage nonbulky Hodgkin lymphoma. Curr Opin Oncol. 2006;18(5):432\u2013436."},{"issue":"1","key":"i1543-2165-135-4-483-b02","series-title":"J Clin Oncol","first-page":"15","article-title":"Chemotherapy or combined modality treatment: the optimal treatment for Hodgkin's disease","volume":"22","author":"Diehl\n              V.","year":"2004","unstructured":"Diehl\n              V. \n          \n          Chemotherapy or combined modality treatment: the optimal treatment for Hodgkin's disease. J Clin Oncol. 2004;22(1):15\u201318."},{"issue":"1","key":"i1543-2165-135-4-483-b03","series-title":"J Clin Oncol","first-page":"62","article-title":"Consolidation radiation after complete remission in Hodgkin's disease following six cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine chemotherapy: is there a need","volume":"22","author":"Laskar\n              S,","year":"2004","unstructured":"Laskar\n              S, \n            \n              Gupta\n              T, \n            \n              Vimal\n              S, \n            et al\n          . Consolidation radiation after complete remission in Hodgkin's disease following six cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine chemotherapy: is there a need? J Clin Oncol. 2004;22(1):62\u201368."},{"issue":"2","key":"i1543-2165-135-4-483-b04","series-title":"J Clin Oncol","first-page":"534","article-title":"Autotransplants for Hodgkin's disease in patients never achieving remission: a report from the Autologous Blood and Marrow Transplant Registry","volume":"17","author":"Lazarus\n              HM,","year":"1999","unstructured":"Lazarus\n              HM, \n            \n              Rowlings\n              PA, \n            \n              Zhang\n              MJ, \n            et al\n          . Autotransplants for Hodgkin's disease in patients never achieving remission: a report from the Autologous Blood and Marrow Transplant Registry. J Clin Oncol. 1999;17(2):534\u2013545."},{"key":"i1543-2165-135-4-483-b05","series-title":"Hematology Am Soc Hematol Educ Program","first-page":"245","article-title":"Therapies for relapsed Hodgkin lymphoma: transplant and non-transplant approaches including immunotherapy","author":"Bartlett\n              NL.","year":"2005","unstructured":"Bartlett\n              NL. \n          \n          Therapies for relapsed Hodgkin lymphoma: transplant and non-transplant approaches including immunotherapy. Hematology Am Soc Hematol Educ Program. 2005;245\u2013251."},{"issue":"1","key":"i1543-2165-135-4-483-b06","series-title":"Br J Haematol","first-page":"3","article-title":"Managing relapsed and refractory Hodgkin lymphoma","volume":"141","author":"Brice\n              P.","year":"2008","unstructured":"Brice\n              P. \n          \n          Managing relapsed and refractory Hodgkin lymphoma. Br J Haematol. 2008;141(1):3\u201313."},{"issue":"11","key":"i1543-2165-135-4-483-b07","series-title":"J Clin Oncol","first-page":"2258","article-title":"Clinical staging versus laparotomy and combined modality with MOPP versus ABVD in early-stage Hodgkin's disease: the H6 twin randomized trials from the European Organization for Research and Treatment of Cancer Lymphoma Cooperative Group","volume":"11","author":"Carde\n              P,","year":"1993","unstructured":"Carde\n              P, \n            \n              Hagenbeek\n              A, \n            \n              Hayat\n              M, \n            et al\n          . Clinical staging versus laparotomy and combined modality with MOPP versus ABVD in early-stage Hodgkin's disease: the H6 twin randomized trials from the European Organization for Research and Treatment of Cancer Lymphoma Cooperative Group. J Clin Oncol. 1993;11(11):2258\u20132272."},{"issue":"2","key":"i1543-2165-135-4-483-b08","series-title":"Int J Radiat Oncol Biol Phys","first-page":"305","article-title":"Randomized trial with early-stage Hodgkin's disease testing 30\u00a0Gy vs. 40\u00a0Gy extended field radiotherapy alone","volume":"36","author":"D\u00fchmke\n              E,","year":"1996","unstructured":"D\u00fchmke\n              E, \n            \n              Diehl\n              V, \n            \n              Loeffler\n              M, \n            et al\n          . Randomized trial with early-stage Hodgkin's disease testing 30\u00a0Gy vs. 40\u00a0Gy extended field radiotherapy alone. Int J Radiat Oncol Biol Phys. 1996;36(2):305\u2013310."},{"issue":"11","key":"i1543-2165-135-4-483-b09","series-title":"Eur J Cancer","first-page":"1841","article-title":"Radiation therapy in clinical stage I and II Hodgkin's disease","volume":"28A","author":"Gospodarowicz\n              MK,","year":"1992","unstructured":"Gospodarowicz\n              MK, \n            \n              Sutcliffe\n              SB, \n            \n              Bergsagel\n              DE, \n            \n              Chua\n              T; \n          \n          Princess Margaret Hospital Lymphoma Group. Radiation therapy in clinical stage I and II Hodgkin's disease. Eur J Cancer. 1992; 28A(11):1841\u20131846."},{"issue":"21","key":"i1543-2165-135-4-483-b10","series-title":"N Engl J Med","first-page":"1506","article-title":"A prognostic score for advanced Hodgkin's disease","volume":"339","author":"Hasenclever\n              D,","unstructured":"Hasenclever\n              D, \n            \n              Diehl\n              V. \n          \n          A prognostic score for advanced Hodgkin's disease. N Engl J Med.1998;339(21):1506\u20131514."},{"key":"i1543-2165-135-4-483-b11","series-title":"Hematology Am Soc Hematol Educ Program","first-page":"225","article-title":"Hodgkin's lymphoma: biology and treatment strategies for primary, refractory and relapsed disease","author":"Diehl\n              V,","year":"2003","unstructured":"Diehl\n              V, \n            \n              Stein\n              H, \n            \n              Hummel\n              M, \n            \n              Zollinger\n              R, \n            \n              Connors\n              JM. \n          \n          Hodgkin's lymphoma: biology and treatment strategies for primary, refractory and relapsed disease. Hematology Am Soc Hematol Educ Program. 2003;225\u2013247."},{"issue":"66","key":"i1543-2165-135-4-483-b12","series-title":"Eur J Haematol Suppl","first-page":"125","article-title":"Current treatment strategies of the German Hodgkin Study Group (GHSG)","author":"Klimm\n              B,","year":"2005","unstructured":"Klimm\n              B, \n            \n              Diehl\n              V, \n            \n              Pfistner\n              B, \n            \n              Engert\n              A. \n          \n          Current treatment strategies of the German Hodgkin Study Group (GHSG). Eur J Haematol Suppl. 2005;(66):125\u2013134."},{"issue":"12","key":"i1543-2165-135-4-483-b13","series-title":"Blood","first-page":"4283","article-title":"The role of cytokines in classical Hodgkin lymphoma","volume":"99","author":"Skinnider\n              BF,","year":"2002","unstructured":"Skinnider\n              BF, \n            \n              Mak\n              TW. \n          \n          The role of cytokines in classical Hodgkin lymphoma. Blood. 2002;99(12):4283\u20134297."},{"issue":"4","key":"i1543-2165-135-4-483-b14","series-title":"Experimental Hematology","first-page":"399","article-title":"Epstein-Barr virus, cytokines, and inflammation: a cocktail for the pathogenesis of Hodgkin's lymphoma","volume":"34","author":"Khan\n              G.","year":"2006","unstructured":"Khan\n              G. \n          \n          Epstein-Barr virus, cytokines, and inflammation: a cocktail for the pathogenesis of Hodgkin's lymphoma. Experimental Hematology. 2006;34(4):399\u2013406."},{"key":"i1543-2165-135-4-483-b15","series-title":"Hematology Am Soc Hematol Educ Program","first-page":"231","article-title":"Immunobiology and pathophysiology of Hodgkin lymphomas","author":"Poppema\n              S.","year":"2005","unstructured":"Poppema\n              S. \n          \n          Immunobiology and pathophysiology of Hodgkin lymphomas. Hematology Am Soc Hematol Educ Program. 2005;231\u2013238."},{"issue":"4","key":"i1543-2165-135-4-483-b16","series-title":"Immunol Today","first-page":"156","article-title":"Hodgkin's disease: a tumor with disturbed immunological pathways","volume":"18","author":"Gruss\n              HJ,","year":"1997","unstructured":"Gruss\n              HJ, \n            \n              Pinto\n              A, \n            \n              Duyster\n              J, \n            \n              Poppema\n              S, \n            \n              Herrmann\n              F. \n          \n          Hodgkin's disease: a tumor with disturbed immunological pathways. Immunol Today. 1997;18(4):156\u2013163."},{"key":"i1543-2165-135-4-483-b17","series-title":"Annu Rev Pathol","first-page":"151","article-title":"Pathogenesis of classical and lymphocyte-predominant Hodgkin lymphoma","volume":"4","author":"Schmitz\n              R,","year":"2009","unstructured":"Schmitz\n              R, \n            \n              Stanelle\n              J, \n            \n              Hansmann\n              ML, \n            \n              Kuppers\n              R. \n          \n          Pathogenesis of classical and lymphocyte-predominant Hodgkin lymphoma. Annu Rev Pathol. 2009;4:151\u2013174."},{"issue":"12","key":"i1543-2165-135-4-483-b18","series-title":"Blood","first-page":"4553","article-title":"From Hodgkin disease to Hodgkin lymphoma: biologic insights and therapeutic potential","volume":"105","author":"Re\n              D,","year":"2005","unstructured":"Re\n              D, \n            \n              Thomas\n              RK, \n            \n              Behringer\n              K, \n            \n              Diehl\n              V. \n          \n          From Hodgkin disease to Hodgkin lymphoma: biologic insights and therapeutic potential. Blood. 2005;105(12):4553\u20134560."},{"issue":"3\u20134","key":"i1543-2165-135-4-483-b19","series-title":"Leuk Lymphoma","first-page":"363","article-title":"The role of chemokines in Hodgkin's disease","volume":"38","author":"Teruya-Feldstein\n              J,","year":"2000","unstructured":"Teruya-Feldstein\n              J, \n            \n              Tosato\n              G, \n            \n              Jaffe\n              ES. \n          \n          The role of chemokines in Hodgkin's disease. Leuk Lymphoma. 2000;38(3\u20134):363\u2013371."},{"issue":"suppl 1","key":"i1543-2165-135-4-483-b20","series-title":"Ann Oncol","first-page":"52","article-title":"Chemokines, cytokines and their receptors in Hodgkin's lymphoma cell lines and tissue","volume":"13","author":"Maggio\n              E,","year":"2002","unstructured":"Maggio\n              E, \n            \n              van den Berg\n              A, \n            \n              Diepstra\n              A, \n            \n              Kluiver\n              J, \n            \n              Visser\n              L, \n            \n              Poppema\n              S. \n          \n          Chemokines, cytokines and their receptors in Hodgkin's lymphoma cell lines and tissue. Ann Oncol. 2002;13(suppl 1):52\u201356."},{"issue":"8","key":"i1543-2165-135-4-483-b21","series-title":"Blood","first-page":"3216","article-title":"IL-6 levels and genotype are associated with risk of young adult Hodgkin lymphoma","volume":"103","author":"Cozen\n              W,","year":"2004","unstructured":"Cozen\n              W, \n            \n              Gill\n              PS, \n            \n              Ingles\n              SA, \n            et al\n          . IL-6 levels and genotype are associated with risk of young adult Hodgkin lymphoma. Blood. 2004;103(8):3216\u20133221."},{"issue":"1","key":"i1543-2165-135-4-483-b22","series-title":"Br J Haematol","first-page":"195","article-title":"Interleukin 6 expression by Hodgkin\/Reed-Sternberg cells is associated with the presence of \u2018B\u2019 symptoms and failure to achieve complete remission in patients with advanced Hodgkin's disease","volume":"118","author":"Reynolds\n              GM,","year":"2002","unstructured":"Reynolds\n              GM, \n            \n              Billingham\n              LJ, \n            \n              Gray\n              LJ, \n            et al\n          . Interleukin 6 expression by Hodgkin\/Reed-Sternberg cells is associated with the presence of \u2018B\u2019 symptoms and failure to achieve complete remission in patients with advanced Hodgkin's disease. Br J Haematol. 2002;118(1):195\u2013201."},{"issue":"3","key":"i1543-2165-135-4-483-b23","series-title":"Haematologica","first-page":"274","article-title":"Serum interleukin-10 levels are an independent prognostic factor for patients with Hodgkin's lymphoma","volume":"86","author":"Vassilakopoulos\n              TP,","year":"2001","unstructured":"Vassilakopoulos\n              TP, \n            \n              Nadali\n              G, \n            \n              Angelopoulou\n              MK, \n            et al\n          . Serum interleukin-10 levels are an independent prognostic factor for patients with Hodgkin's lymphoma. Haematologica. 2001;86(3):274\u2013281."},{"issue":"6","key":"i1543-2165-135-4-483-b24","series-title":"Leuk Lymphoma","first-page":"1203","article-title":"The role of interleukin 13 in classical Hodgkin lymphoma","volume":"43","author":"Skinnider\n              BF,","year":"2002","unstructured":"Skinnider\n              BF, \n            \n              Kapp\n              U, \n            \n              Mak\n              TW. \n          \n          The role of interleukin 13 in classical Hodgkin lymphoma. Leuk Lymphoma. 2002;43(6):1203\u20131210."},{"issue":"9","key":"i1543-2165-135-4-483-b25","series-title":"Cancer Res","first-page":"2118","article-title":"Serum interleukin 6 levels are elevated in lymphoma patients and correlate with survival in advanced Hodgkin's disease and with B symptoms","volume":"53","author":"Kurzrock\n              R,","year":"1993","unstructured":"Kurzrock\n              R, \n            \n              Redman\n              J, \n            \n              Cabanillas\n              F, \n            \n              Jones\n              D, \n            \n              Rothberg\n              J, \n            \n              Talpaz\n              M. \n          \n          Serum interleukin 6 levels are elevated in lymphoma patients and correlate with survival in advanced Hodgkin's disease and with B symptoms. Cancer Res. 1993;53(9):2118\u20132122."},{"issue":"1","key":"i1543-2165-135-4-483-b26","series-title":"Am J Med","first-page":"21","article-title":"Clinical correlates of elevated levels of interleukin-6 in patients with untreated Hodgkin's disease","volume":"102","author":"Seymor\n              JF,","year":"1997","unstructured":"Seymor\n              JF, \n            \n              Talpaz\n              M, \n            \n              Hagemeister\n              FB, \n            \n              Cabanillas\n              F, \n            \n              Kurzrock\n              R. \n          \n          Clinical correlates of elevated levels of interleukin-6 in patients with untreated Hodgkin's disease. Am J Med. 1997;102(1):21\u201328."},{"issue":"4","key":"i1543-2165-135-4-483-b27","series-title":"Ann Oncol","first-page":"433","article-title":"Interleukin-10 levels are often elevated in serum of adults with Hodgkin's disease and are associated with inferior failure-free survival","volume":"10","author":"Sarris\n              AH,","year":"1999","unstructured":"Sarris\n              AH, \n            \n              Kliche\n              KO, \n            \n              Pethambaram\n              P, \n            et al\n          . Interleukin-10 levels are often elevated in serum of adults with Hodgkin's disease and are associated with inferior failure-free survival. Ann Oncol. 1999;10(4):433\u2013440."},{"issue":"60","key":"i1543-2165-135-4-483-b28","series-title":"Clin Cancer Res","first-page":"2114","article-title":"Expression of Epstein-Barr virus latent membrane protein-1 in Hodgkin and Reed-Sternberg cells of classical Hodgkin's lymphoma: associations with presenting features, serum interleukin 10 levels, and clinical outcome","volume":"9","author":"Herling\n              M,","year":"2003","unstructured":"Herling\n              M, \n            \n              Rassidakis\n              GZ, \n            \n              Medeiros\n              JL, \n            et al\n          . Expression of Epstein-Barr virus latent membrane protein-1 in Hodgkin and Reed-Sternberg cells of classical Hodgkin's lymphoma: associations with presenting features, serum interleukin 10 levels, and clinical outcome. Clin Cancer Res. 2003;9(60):2114\u20132120."},{"issue":"7","key":"i1543-2165-135-4-483-b29","series-title":"Blood","first-page":"2918","article-title":"Frequent expression of interleukin-10 by Epstein-Barr Virus-harboring tumor cells of Hodgkin's disease","volume":"87","author":"Herbst\n              H,","year":"1996","unstructured":"Herbst\n              H, \n            \n              Foss\n              HD, \n            \n              Samol\n              J, \n            et al\n          . Frequent expression of interleukin-10 by Epstein-Barr Virus-harboring tumor cells of Hodgkin's disease. Blood. 1996;87(7):2918\u20132929."},{"issue":"11","key":"i1543-2165-135-4-483-b30","series-title":"Blood","first-page":"2413","article-title":"Expression of interleukin-6 and interleukin-6 receptor in Hodgkin's disease","volume":"77","author":"Jucker\n              M,","year":"1991","unstructured":"Jucker\n              M, \n            \n              Abts\n              H, \n            \n              Li\n              W, \n            et al\n          . Expression of interleukin-6 and interleukin-6 receptor in Hodgkin's disease. Blood. 1991;77(11):2413\u20132418."},{"issue":"4","key":"i1543-2165-135-4-483-b31","series-title":"Br J Haematol","first-page":"627","article-title":"Lymhpotoxin, tumor necrosis factor and interleukin-6 gene transcripts are present in Hodgkin and Reed-Sternberg cells of most Hodgkin's disease cases","volume":"84","author":"Foss\n              HD,","year":"1993","unstructured":"Foss\n              HD, \n            \n              Herbst\n              H, \n            \n              Oelman\n              E, \n            et al\n          . Lymhpotoxin, tumor necrosis factor and interleukin-6 gene transcripts are present in Hodgkin and Reed-Sternberg cells of most Hodgkin's disease cases. Br J Haematol. 1993;84(4):627\u2013635."},{"issue":"2","key":"i1543-2165-135-4-483-b32","series-title":"J Pathol","first-page":"143","article-title":"Quantitative immunohistochemical analysis of cytokine profiles in Epstein-Barr virus\u2013positive and negative cases of Hodgkin's disease","volume":"190","author":"Duckers\n              DF,","year":"2000","unstructured":"Duckers\n              DF, \n            \n              Jaspars\n              LH, \n            \n              Voss\n              W, \n            et al\n          . Quantitative immunohistochemical analysis of cytokine profiles in Epstein-Barr virus\u2013positive and negative cases of Hodgkin's disease. J Pathol. 2000;190(2):143\u2013149."},{"key":"i1543-2165-135-4-483-b33","series-title":"Adv Immunol","first-page":"1","article-title":"Interleukin-6 in biology and medicine","volume":"54","author":"Akira\n              S,","year":"1993","unstructured":"Akira\n              S, \n            \n              Taga\n              T, \n            \n              Kishimoto\n              T. \n          \n          Interleukin-6 in biology and medicine. Adv Immunol. 1993;54:1\u201378."},{"issue":"1","key":"i1543-2165-135-4-483-b34","series-title":"Med Res Rev","first-page":"87","article-title":"The biological effects of interleukin 6","volume":"16","author":"Barton\n              BE.","year":"1996","unstructured":"Barton\n              BE. \n          \n          The biological effects of interleukin 6. Med Res Rev. 1996;16(1):87\u2013109."},{"issue":"3","key":"i1543-2165-135-4-483-b35","series-title":"J Pathol","first-page":"299","article-title":"Modulation of interleukin-6 expression in Hodgkin and Reed-Sternberg cells by Epstein-Barr virus","volume":"182","author":"Herbst\n              H,","year":"1997","unstructured":"Herbst\n              H, \n            \n              Samol\n              J, \n            \n              Foss\n              HD, \n            \n              Raff\n              T, \n            \n              Niedobitek\n              G. \n          \n          Modulation of interleukin-6 expression in Hodgkin and Reed-Sternberg cells by Epstein-Barr virus. J Pathol. 1997;182(3):299\u2013306."},{"issue":"1","key":"i1543-2165-135-4-483-b36","series-title":"J Clin Investig","first-page":"424","article-title":"Interleukin-10 prevents spontaneous death of germinal center B cells by induction of the bcl-2 protein","volume":"93","author":"Levy\n              Y,","year":"1994","unstructured":"Levy\n              Y, \n            \n              Brouet\n              JC. \n          \n          Interleukin-10 prevents spontaneous death of germinal center B cells by induction of the bcl-2 protein. J Clin Investig. 1994;93(1):424\u2013428."},{"issue":"3","key":"i1543-2165-135-4-483-b37","series-title":"Ann Hematol","first-page":"110","article-title":"Poor clinical outcome of patients with Hodgkin's disease and elevated interleukin-10 serum levels: clinical significance of interleukin-10 serum levels for Hodgkin's disease","volume":"79","author":"Bohlen\n              H,","year":"2000","unstructured":"Bohlen\n              H, \n            \n              Kessler\n              M, \n            \n              Sextro\n              M, \n            \n              Diehl\n              V, \n            \n              Tesch\n              H. \n          \n          Poor clinical outcome of patients with Hodgkin's disease and elevated interleukin-10 serum levels: clinical significance of interleukin-10 serum levels for Hodgkin's disease. Ann Hematol. 2000;79(3):110\u2013113."},{"issue":"1","key":"i1543-2165-135-4-483-b38","series-title":"Med Oncol","first-page":"59","article-title":"Elevated pretreatment serum of IL-10 are associated with poor prognosis in Hodgkin's disease, the Milan Cancer Institute experience","volume":"17","author":"Viviani\n              S,","year":"2000","unstructured":"Viviani\n              S, \n            \n              Notti\n              P, \n            \n              Bonfante\n              V, \n            \n              Verderio\n              P, \n            \n              Valagussa\n              P, \n            \n              Bonddonna\n              G. \n          \n          Elevated pretreatment serum of IL-10 are associated with poor prognosis in Hodgkin's disease, the Milan Cancer Institute experience. Med Oncol. 2000;17(1):59\u201363."},{"issue":"11","key":"i1543-2165-135-4-483-b39","series-title":"Leuk Lymphoma","first-page":"2091","article-title":"Elevated pretreatment interleukin-10 serum level is an International Prognostic Score (IPS)\u2013independent risk factor for early treatment failure in advanced stage Hodgkin lymphoma","volume":"49","author":"Rautert\n              R,","year":"2008","unstructured":"Rautert\n              R, \n            \n              Schinkothe\n              T, \n            \n              Franklin\n              J, \n            et al\n          . Elevated pretreatment interleukin-10 serum level is an International Prognostic Score (IPS)\u2013independent risk factor for early treatment failure in advanced stage Hodgkin lymphoma. Leuk Lymphoma. 2008;49(11):2091\u20132098."},{"issue":"12","key":"i1543-2165-135-4-483-b40","series-title":"J Exp Med","first-page":"1939","article-title":"Interleukin 13 is secreted by and stimulates the growth of Reed-Sternberg cells","volume":"189","author":"Kapp\n              U,","year":"1999","unstructured":"Kapp\n              U, \n            \n              Yeh\n              WC, \n            \n              Patterson\n              B, \n            et al\n          . Interleukin 13 is secreted by and stimulates the growth of Reed-Sternberg cells. J Exp Med. 1999;189(12):1939\u20131946."},{"issue":"4","key":"i1543-2165-135-4-483-b41","series-title":"Histopathology","first-page":"368","article-title":"Interleukin-13 and interleukin-13 receptor in Hodgkin's disease: possible autocrine mechanism and involvement in fibrosis","volume":"38","author":"Ohshima\n              K,","year":"2001","unstructured":"Ohshima\n              K, \n            \n              Akaiwa\n              M, \n            \n              Umeshita\n              R, \n            \n              Suzumiya\n              J, \n            \n              Izuhara\n              K, \n            \n              Kikuchi\n              M. \n          \n          Interleukin-13 and interleukin-13 receptor in Hodgkin's disease: possible autocrine mechanism and involvement in fibrosis. Histopathology. 2001;38(4):368\u2013375."},{"issue":"1","key":"i1543-2165-135-4-483-b42","series-title":"Blood","first-page":"250","article-title":"Interleukin 13 and interleukin 13 receptor are frequently expressed by Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma","volume":"97","author":"Skinnider\n              BF,","year":"2001","unstructured":"Skinnider\n              BF, \n            \n              Elia\n              AJ, \n            \n              Gascoyne\n              RD, \n            et al\n          . Interleukin 13 and interleukin 13 receptor are frequently expressed by Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma. Blood. 2001;97(1):250\u2013255."},{"issue":"13","key":"i1543-2165-135-4-483-b43","series-title":"J Clin Oncol","first-page":"1732","article-title":"Plasma Cytokine and soluble receptor signature predicts outcome of patients with classical Hodgkin's lymphoma: a study from the Groupe d'Etude des Lymphomes de l'Adulte","volume":"25","author":"Casasnovas\n              RO,","year":"2007","unstructured":"Casasnovas\n              RO, \n            \n              Mounier\n              N, \n            \n              Brice\n              P, \n            et al\n          . Plasma Cytokine and soluble receptor signature predicts outcome of patients with classical Hodgkin's lymphoma: a study from the Groupe d'Etude des Lymphomes de l'Adulte. J Clin Oncol. 2007;25(13):1732\u20131740."},{"issue":"11","key":"i1543-2165-135-4-483-b44","series-title":"J Clin Oncol","first-page":"1630","article-title":"Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting","volume":"7","author":"Lister\n              TA,","year":"1989","unstructured":"Lister\n              TA, \n            \n              Crowther\n              D, \n            \n              Sutcliffe\n              SB, \n            et al\n          . Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting. J Clin Oncol. 1989;7(11):1630\u20131636."},{"issue":"2","key":"i1543-2165-135-4-483-b45","series-title":"Am J Clin Pathol","first-page":"284","article-title":"Human papillomavirus and Epstein-Barr virus infection, p53 expression, and cellular proliferation in laryngeal carcinoma","volume":"126","author":"de Oliveira\n              DE,","year":"2006","unstructured":"de Oliveira\n              DE, \n            \n              Bacchi\n              MM, \n            \n              Macarenco\n              RS, \n            \n              Tagliarini\n              JV, \n            \n              Cordeiro\n              RC, \n            \n              Bacchi\n              CE. \n          \n          Human papillomavirus and Epstein-Barr virus infection, p53 expression, and cellular proliferation in laryngeal carcinoma. Am J Clin Pathol. 2006;126(2):284\u2013293."},{"issue":"5","key":"i1543-2165-135-4-483-b46","series-title":"Hematol Oncol Clin North Am","first-page":"805","article-title":"The potential role of innate immunity in the pathogenesis of Hodgkin's lymphoma","volume":"21","author":"Enblad\n              G,","year":"2007","unstructured":"Enblad\n              G, \n            \n              Molin\n              D, \n            \n              Glimelius\n              I, \n            \n              Fisher\n              M, \n            \n              Nilsson\n              G. \n          \n          The potential role of innate immunity in the pathogenesis of Hodgkin's lymphoma. Hematol Oncol Clin North Am. 2007;21(5):805\u2013823."},{"issue":"6","key":"i1543-2165-135-4-483-b47","series-title":"J Immunol","first-page":"3463","article-title":"Directing transition from innate to acquired immunity: defining a role for IL-6","volume":"175","author":"Jones\n              AS.","year":"2005","unstructured":"Jones\n              AS. \n          \n          Directing transition from innate to acquired immunity: defining a role for IL-6. J Immunol. 2005;175(6):3463\u20133468."},{"issue":"2","key":"i1543-2165-135-4-483-b48","series-title":"J Leukoc Biol","first-page":"227","article-title":"Interleukin-6 biology is coordinated by membrane-bound and soluble receptors: role in inflammation and cancer","volume":"80","author":"Rose-John\n              S,","year":"2006","unstructured":"Rose-John\n              S, \n            \n              Scheller\n              J, \n            \n              Elson\n              G, \n            \n              Jones\n              SA. \n          \n          Interleukin-6 biology is coordinated by membrane-bound and soluble receptors: role in inflammation and cancer. J Leukoc Biol. 2006;80(2):227\u2013236."},{"issue":"6","key":"i1543-2165-135-4-483-b49","series-title":"Hematol Oncol","first-page":"307","article-title":"Increased levels of circulating interleukin-6 in patients with Hodgkin's disease","volume":"9","author":"Gause\n              A,","year":"1991","unstructured":"Gause\n              A, \n            \n              Scholz\n              R, \n            \n              Klein\n              S, \n            et al\n          . Increased levels of circulating interleukin-6 in patients with Hodgkin's disease. Hematol Oncol. 1991;9(6):307\u2013313."},{"issue":"6","key":"i1543-2165-135-4-483-b50","series-title":"Cytokine","first-page":"251","article-title":"Cancer cachexia is mediated in part by the induction of IL-6\u2013like cytokines from the spleen","volume":"16","author":"Barton\n              BE,","year":"2001","unstructured":"Barton\n              BE, \n            \n              Murphy\n              TF. \n          \n          Cancer cachexia is mediated in part by the induction of IL-6\u2013like cytokines from the spleen. Cytokine. 2001;16(6):251\u2013257."},{"issue":"1","key":"i1543-2165-135-4-483-b51","series-title":"Clin Immunol Immunopathol","first-page":"16","article-title":"IL-6: insights into novel biological activities","volume":"85","author":"Barton\n              BE.","year":"1997","unstructured":"Barton\n              BE. \n          \n          IL-6: insights into novel biological activities. Clin Immunol Immunopathol. 1997;85(1):16\u201320."},{"issue":"9","key":"i1543-2165-135-4-483-b52","series-title":"Blood","first-page":"2877","article-title":"Interleukin-13 levels in serum from patients with Hodgkin disease and healthy volunteers","volume":"98","author":"Fiumara\n              P,","year":"2001","unstructured":"Fiumara\n              P, \n            \n              Cabanillas\n              F, \n            \n              Younes\n              A. \n          \n          Interleukin-13 levels in serum from patients with Hodgkin disease and healthy volunteers. Blood. 2001;98(9):2877\u20132878."},{"issue":"5","key":"i1543-2165-135-4-483-b01","series-title":"Curr Opin Oncol","first-page":"432","article-title":"Treatment of early-stage nonbulky Hodgkin lymphoma","volume":"18","author":"Straus\n              DJ.","year":"2006","unstructured":"Straus\n              DJ. \n          \n          Treatment of early-stage nonbulky Hodgkin lymphoma. Curr Opin Oncol. 2006;18(5):432\u2013436."},{"issue":"1","key":"i1543-2165-135-4-483-b02","series-title":"J Clin Oncol","first-page":"15","article-title":"Chemotherapy or combined modality treatment: the optimal treatment for Hodgkin's disease","volume":"22","author":"Diehl\n              V.","year":"2004","unstructured":"Diehl\n              V. \n          \n          Chemotherapy or combined modality treatment: the optimal treatment for Hodgkin's disease. J Clin Oncol. 2004;22(1):15\u201318."},{"issue":"1","key":"i1543-2165-135-4-483-b03","series-title":"J Clin Oncol","first-page":"62","article-title":"Consolidation radiation after complete remission in Hodgkin's disease following six cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine chemotherapy: is there a need","volume":"22","author":"Laskar\n              S,","year":"2004","unstructured":"Laskar\n              S, \n            \n              Gupta\n              T, \n            \n              Vimal\n              S, \n            et al\n          . Consolidation radiation after complete remission in Hodgkin's disease following six cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine chemotherapy: is there a need? J Clin Oncol. 2004;22(1):62\u201368."},{"issue":"2","key":"i1543-2165-135-4-483-b04","series-title":"J Clin Oncol","first-page":"534","article-title":"Autotransplants for Hodgkin's disease in patients never achieving remission: a report from the Autologous Blood and Marrow Transplant Registry","volume":"17","author":"Lazarus\n              HM,","year":"1999","unstructured":"Lazarus\n              HM, \n            \n              Rowlings\n              PA, \n            \n              Zhang\n              MJ, \n            et al\n          . Autotransplants for Hodgkin's disease in patients never achieving remission: a report from the Autologous Blood and Marrow Transplant Registry. J Clin Oncol. 1999;17(2):534\u2013545."},{"key":"i1543-2165-135-4-483-b05","series-title":"Hematology Am Soc Hematol Educ Program","first-page":"245","article-title":"Therapies for relapsed Hodgkin lymphoma: transplant and non-transplant approaches including immunotherapy","author":"Bartlett\n              NL.","year":"2005","unstructured":"Bartlett\n              NL. \n          \n          Therapies for relapsed Hodgkin lymphoma: transplant and non-transplant approaches including immunotherapy. Hematology Am Soc Hematol Educ Program. 2005;245\u2013251."},{"issue":"1","key":"i1543-2165-135-4-483-b06","series-title":"Br J Haematol","first-page":"3","article-title":"Managing relapsed and refractory Hodgkin lymphoma","volume":"141","author":"Brice\n              P.","year":"2008","unstructured":"Brice\n              P. \n          \n          Managing relapsed and refractory Hodgkin lymphoma. Br J Haematol. 2008;141(1):3\u201313."},{"issue":"11","key":"i1543-2165-135-4-483-b07","series-title":"J Clin Oncol","first-page":"2258","article-title":"Clinical staging versus laparotomy and combined modality with MOPP versus ABVD in early-stage Hodgkin's disease: the H6 twin randomized trials from the European Organization for Research and Treatment of Cancer Lymphoma Cooperative Group","volume":"11","author":"Carde\n              P,","year":"1993","unstructured":"Carde\n              P, \n            \n              Hagenbeek\n              A, \n            \n              Hayat\n              M, \n            et al\n          . Clinical staging versus laparotomy and combined modality with MOPP versus ABVD in early-stage Hodgkin's disease: the H6 twin randomized trials from the European Organization for Research and Treatment of Cancer Lymphoma Cooperative Group. J Clin Oncol. 1993;11(11):2258\u20132272."},{"issue":"2","key":"i1543-2165-135-4-483-b08","series-title":"Int J Radiat Oncol Biol Phys","first-page":"305","article-title":"Randomized trial with early-stage Hodgkin's disease testing 30\u00a0Gy vs. 40\u00a0Gy extended field radiotherapy alone","volume":"36","author":"D\u00fchmke\n              E,","year":"1996","unstructured":"D\u00fchmke\n              E, \n            \n              Diehl\n              V, \n            \n              Loeffler\n              M, \n            et al\n          . Randomized trial with early-stage Hodgkin's disease testing 30\u00a0Gy vs. 40\u00a0Gy extended field radiotherapy alone. Int J Radiat Oncol Biol Phys. 1996;36(2):305\u2013310."},{"issue":"11","key":"i1543-2165-135-4-483-b09","series-title":"Eur J Cancer","first-page":"1841","article-title":"Radiation therapy in clinical stage I and II Hodgkin's disease","volume":"28A","author":"Gospodarowicz\n              MK,","year":"1992","unstructured":"Gospodarowicz\n              MK, \n            \n              Sutcliffe\n              SB, \n            \n              Bergsagel\n              DE, \n            \n              Chua\n              T; \n          \n          Princess Margaret Hospital Lymphoma Group. Radiation therapy in clinical stage I and II Hodgkin's disease. Eur J Cancer. 1992; 28A(11):1841\u20131846."},{"issue":"21","key":"i1543-2165-135-4-483-b10","series-title":"N Engl J Med","first-page":"1506","article-title":"A prognostic score for advanced Hodgkin's disease","volume":"339","author":"Hasenclever\n              D,","unstructured":"Hasenclever\n              D, \n            \n              Diehl\n              V. \n          \n          A prognostic score for advanced Hodgkin's disease. N Engl J Med.1998;339(21):1506\u20131514."},{"key":"i1543-2165-135-4-483-b11","series-title":"Hematology Am Soc Hematol Educ Program","first-page":"225","article-title":"Hodgkin's lymphoma: biology and treatment strategies for primary, refractory and relapsed disease","author":"Diehl\n              V,","year":"2003","unstructured":"Diehl\n              V, \n            \n              Stein\n              H, \n            \n              Hummel\n              M, \n            \n              Zollinger\n              R, \n            \n              Connors\n              JM. \n          \n          Hodgkin's lymphoma: biology and treatment strategies for primary, refractory and relapsed disease. Hematology Am Soc Hematol Educ Program. 2003;225\u2013247."},{"issue":"66","key":"i1543-2165-135-4-483-b12","series-title":"Eur J Haematol Suppl","first-page":"125","article-title":"Current treatment strategies of the German Hodgkin Study Group (GHSG)","author":"Klimm\n              B,","year":"2005","unstructured":"Klimm\n              B, \n            \n              Diehl\n              V, \n            \n              Pfistner\n              B, \n            \n              Engert\n              A. \n          \n          Current treatment strategies of the German Hodgkin Study Group (GHSG). Eur J Haematol Suppl. 2005;(66):125\u2013134."},{"issue":"12","key":"i1543-2165-135-4-483-b13","series-title":"Blood","first-page":"4283","article-title":"The role of cytokines in classical Hodgkin lymphoma","volume":"99","author":"Skinnider\n              BF,","year":"2002","unstructured":"Skinnider\n              BF, \n            \n              Mak\n              TW. \n          \n          The role of cytokines in classical Hodgkin lymphoma. Blood. 2002;99(12):4283\u20134297."},{"issue":"4","key":"i1543-2165-135-4-483-b14","series-title":"Experimental Hematology","first-page":"399","article-title":"Epstein-Barr virus, cytokines, and inflammation: a cocktail for the pathogenesis of Hodgkin's lymphoma","volume":"34","author":"Khan\n              G.","year":"2006","unstructured":"Khan\n              G. \n          \n          Epstein-Barr virus, cytokines, and inflammation: a cocktail for the pathogenesis of Hodgkin's lymphoma. Experimental Hematology. 2006;34(4):399\u2013406."},{"key":"i1543-2165-135-4-483-b15","series-title":"Hematology Am Soc Hematol Educ Program","first-page":"231","article-title":"Immunobiology and pathophysiology of Hodgkin lymphomas","author":"Poppema\n              S.","year":"2005","unstructured":"Poppema\n              S. \n          \n          Immunobiology and pathophysiology of Hodgkin lymphomas. Hematology Am Soc Hematol Educ Program. 2005;231\u2013238."},{"issue":"4","key":"i1543-2165-135-4-483-b16","series-title":"Immunol Today","first-page":"156","article-title":"Hodgkin's disease: a tumor with disturbed immunological pathways","volume":"18","author":"Gruss\n              HJ,","year":"1997","unstructured":"Gruss\n              HJ, \n            \n              Pinto\n              A, \n            \n              Duyster\n              J, \n            \n              Poppema\n              S, \n            \n              Herrmann\n              F. \n          \n          Hodgkin's disease: a tumor with disturbed immunological pathways. Immunol Today. 1997;18(4):156\u2013163."},{"key":"i1543-2165-135-4-483-b17","series-title":"Annu Rev Pathol","first-page":"151","article-title":"Pathogenesis of classical and lymphocyte-predominant Hodgkin lymphoma","volume":"4","author":"Schmitz\n              R,","year":"2009","unstructured":"Schmitz\n              R, \n            \n              Stanelle\n              J, \n            \n              Hansmann\n              ML, \n            \n              Kuppers\n              R. \n          \n          Pathogenesis of classical and lymphocyte-predominant Hodgkin lymphoma. Annu Rev Pathol. 2009;4:151\u2013174."},{"issue":"12","key":"i1543-2165-135-4-483-b18","series-title":"Blood","first-page":"4553","article-title":"From Hodgkin disease to Hodgkin lymphoma: biologic insights and therapeutic potential","volume":"105","author":"Re\n              D,","year":"2005","unstructured":"Re\n              D, \n            \n              Thomas\n              RK, \n            \n              Behringer\n              K, \n            \n              Diehl\n              V. \n          \n          From Hodgkin disease to Hodgkin lymphoma: biologic insights and therapeutic potential. Blood. 2005;105(12):4553\u20134560."},{"issue":"3\u20134","key":"i1543-2165-135-4-483-b19","series-title":"Leuk Lymphoma","first-page":"363","article-title":"The role of chemokines in Hodgkin's disease","volume":"38","author":"Teruya-Feldstein\n              J,","year":"2000","unstructured":"Teruya-Feldstein\n              J, \n            \n              Tosato\n              G, \n            \n              Jaffe\n              ES. \n          \n          The role of chemokines in Hodgkin's disease. Leuk Lymphoma. 2000;38(3\u20134):363\u2013371."},{"issue":"suppl 1","key":"i1543-2165-135-4-483-b20","series-title":"Ann Oncol","first-page":"52","article-title":"Chemokines, cytokines and their receptors in Hodgkin's lymphoma cell lines and tissue","volume":"13","author":"Maggio\n              E,","year":"2002","unstructured":"Maggio\n              E, \n            \n              van den Berg\n              A, \n            \n              Diepstra\n              A, \n            \n              Kluiver\n              J, \n            \n              Visser\n              L, \n            \n              Poppema\n              S. \n          \n          Chemokines, cytokines and their receptors in Hodgkin's lymphoma cell lines and tissue. Ann Oncol. 2002;13(suppl 1):52\u201356."},{"issue":"8","key":"i1543-2165-135-4-483-b21","series-title":"Blood","first-page":"3216","article-title":"IL-6 levels and genotype are associated with risk of young adult Hodgkin lymphoma","volume":"103","author":"Cozen\n              W,","year":"2004","unstructured":"Cozen\n              W, \n            \n              Gill\n              PS, \n            \n              Ingles\n              SA, \n            et al\n          . IL-6 levels and genotype are associated with risk of young adult Hodgkin lymphoma. Blood. 2004;103(8):3216\u20133221."},{"issue":"1","key":"i1543-2165-135-4-483-b22","series-title":"Br J Haematol","first-page":"195","article-title":"Interleukin 6 expression by Hodgkin\/Reed-Sternberg cells is associated with the presence of \u2018B\u2019 symptoms and failure to achieve complete remission in patients with advanced Hodgkin's disease","volume":"118","author":"Reynolds\n              GM,","year":"2002","unstructured":"Reynolds\n              GM, \n            \n              Billingham\n              LJ, \n            \n              Gray\n              LJ, \n            et al\n          . Interleukin 6 expression by Hodgkin\/Reed-Sternberg cells is associated with the presence of \u2018B\u2019 symptoms and failure to achieve complete remission in patients with advanced Hodgkin's disease. Br J Haematol. 2002;118(1):195\u2013201."},{"issue":"3","key":"i1543-2165-135-4-483-b23","series-title":"Haematologica","first-page":"274","article-title":"Serum interleukin-10 levels are an independent prognostic factor for patients with Hodgkin's lymphoma","volume":"86","author":"Vassilakopoulos\n              TP,","year":"2001","unstructured":"Vassilakopoulos\n              TP, \n            \n              Nadali\n              G, \n            \n              Angelopoulou\n              MK, \n            et al\n          . Serum interleukin-10 levels are an independent prognostic factor for patients with Hodgkin's lymphoma. Haematologica. 2001;86(3):274\u2013281."},{"issue":"6","key":"i1543-2165-135-4-483-b24","series-title":"Leuk Lymphoma","first-page":"1203","article-title":"The role of interleukin 13 in classical Hodgkin lymphoma","volume":"43","author":"Skinnider\n              BF,","year":"2002","unstructured":"Skinnider\n              BF, \n            \n              Kapp\n              U, \n            \n              Mak\n              TW. \n          \n          The role of interleukin 13 in classical Hodgkin lymphoma. Leuk Lymphoma. 2002;43(6):1203\u20131210."},{"issue":"9","key":"i1543-2165-135-4-483-b25","series-title":"Cancer Res","first-page":"2118","article-title":"Serum interleukin 6 levels are elevated in lymphoma patients and correlate with survival in advanced Hodgkin's disease and with B symptoms","volume":"53","author":"Kurzrock\n              R,","year":"1993","unstructured":"Kurzrock\n              R, \n            \n              Redman\n              J, \n            \n              Cabanillas\n              F, \n            \n              Jones\n              D, \n            \n              Rothberg\n              J, \n            \n              Talpaz\n              M. \n          \n          Serum interleukin 6 levels are elevated in lymphoma patients and correlate with survival in advanced Hodgkin's disease and with B symptoms. Cancer Res. 1993;53(9):2118\u20132122."},{"issue":"1","key":"i1543-2165-135-4-483-b26","series-title":"Am J Med","first-page":"21","article-title":"Clinical correlates of elevated levels of interleukin-6 in patients with untreated Hodgkin's disease","volume":"102","author":"Seymor\n              JF,","year":"1997","unstructured":"Seymor\n              JF, \n            \n              Talpaz\n              M, \n            \n              Hagemeister\n              FB, \n            \n              Cabanillas\n              F, \n            \n              Kurzrock\n              R. \n          \n          Clinical correlates of elevated levels of interleukin-6 in patients with untreated Hodgkin's disease. Am J Med. 1997;102(1):21\u201328."},{"issue":"4","key":"i1543-2165-135-4-483-b27","series-title":"Ann Oncol","first-page":"433","article-title":"Interleukin-10 levels are often elevated in serum of adults with Hodgkin's disease and are associated with inferior failure-free survival","volume":"10","author":"Sarris\n              AH,","year":"1999","unstructured":"Sarris\n              AH, \n            \n              Kliche\n              KO, \n            \n              Pethambaram\n              P, \n            et al\n          . Interleukin-10 levels are often elevated in serum of adults with Hodgkin's disease and are associated with inferior failure-free survival. Ann Oncol. 1999;10(4):433\u2013440."},{"issue":"60","key":"i1543-2165-135-4-483-b28","series-title":"Clin Cancer Res","first-page":"2114","article-title":"Expression of Epstein-Barr virus latent membrane protein-1 in Hodgkin and Reed-Sternberg cells of classical Hodgkin's lymphoma: associations with presenting features, serum interleukin 10 levels, and clinical outcome","volume":"9","author":"Herling\n              M,","year":"2003","unstructured":"Herling\n              M, \n            \n              Rassidakis\n              GZ, \n            \n              Medeiros\n              JL, \n            et al\n          . Expression of Epstein-Barr virus latent membrane protein-1 in Hodgkin and Reed-Sternberg cells of classical Hodgkin's lymphoma: associations with presenting features, serum interleukin 10 levels, and clinical outcome. Clin Cancer Res. 2003;9(60):2114\u20132120."},{"issue":"7","key":"i1543-2165-135-4-483-b29","series-title":"Blood","first-page":"2918","article-title":"Frequent expression of interleukin-10 by Epstein-Barr Virus-harboring tumor cells of Hodgkin's disease","volume":"87","author":"Herbst\n              H,","year":"1996","unstructured":"Herbst\n              H, \n            \n              Foss\n              HD, \n            \n              Samol\n              J, \n            et al\n          . Frequent expression of interleukin-10 by Epstein-Barr Virus-harboring tumor cells of Hodgkin's disease. Blood. 1996;87(7):2918\u20132929."},{"issue":"11","key":"i1543-2165-135-4-483-b30","series-title":"Blood","first-page":"2413","article-title":"Expression of interleukin-6 and interleukin-6 receptor in Hodgkin's disease","volume":"77","author":"Jucker\n              M,","year":"1991","unstructured":"Jucker\n              M, \n            \n              Abts\n              H, \n            \n              Li\n              W, \n            et al\n          . Expression of interleukin-6 and interleukin-6 receptor in Hodgkin's disease. Blood. 1991;77(11):2413\u20132418."},{"issue":"4","key":"i1543-2165-135-4-483-b31","series-title":"Br J Haematol","first-page":"627","article-title":"Lymhpotoxin, tumor necrosis factor and interleukin-6 gene transcripts are present in Hodgkin and Reed-Sternberg cells of most Hodgkin's disease cases","volume":"84","author":"Foss\n              HD,","year":"1993","unstructured":"Foss\n              HD, \n            \n              Herbst\n              H, \n            \n              Oelman\n              E, \n            et al\n          . Lymhpotoxin, tumor necrosis factor and interleukin-6 gene transcripts are present in Hodgkin and Reed-Sternberg cells of most Hodgkin's disease cases. Br J Haematol. 1993;84(4):627\u2013635."},{"issue":"2","key":"i1543-2165-135-4-483-b32","series-title":"J Pathol","first-page":"143","article-title":"Quantitative immunohistochemical analysis of cytokine profiles in Epstein-Barr virus\u2013positive and negative cases of Hodgkin's disease","volume":"190","author":"Duckers\n              DF,","year":"2000","unstructured":"Duckers\n              DF, \n            \n              Jaspars\n              LH, \n            \n              Voss\n              W, \n            et al\n          . Quantitative immunohistochemical analysis of cytokine profiles in Epstein-Barr virus\u2013positive and negative cases of Hodgkin's disease. J Pathol. 2000;190(2):143\u2013149."},{"key":"i1543-2165-135-4-483-b33","series-title":"Adv Immunol","first-page":"1","article-title":"Interleukin-6 in biology and medicine","volume":"54","author":"Akira\n              S,","year":"1993","unstructured":"Akira\n              S, \n            \n              Taga\n              T, \n            \n              Kishimoto\n              T. \n          \n          Interleukin-6 in biology and medicine. Adv Immunol. 1993;54:1\u201378."},{"issue":"1","key":"i1543-2165-135-4-483-b34","series-title":"Med Res Rev","first-page":"87","article-title":"The biological effects of interleukin 6","volume":"16","author":"Barton\n              BE.","year":"1996","unstructured":"Barton\n              BE. \n          \n          The biological effects of interleukin 6. Med Res Rev. 1996;16(1):87\u2013109."},{"issue":"3","key":"i1543-2165-135-4-483-b35","series-title":"J Pathol","first-page":"299","article-title":"Modulation of interleukin-6 expression in Hodgkin and Reed-Sternberg cells by Epstein-Barr virus","volume":"182","author":"Herbst\n              H,","year":"1997","unstructured":"Herbst\n              H, \n            \n              Samol\n              J, \n            \n              Foss\n              HD, \n            \n              Raff\n              T, \n            \n              Niedobitek\n              G. \n          \n          Modulation of interleukin-6 expression in Hodgkin and Reed-Sternberg cells by Epstein-Barr virus. J Pathol. 1997;182(3):299\u2013306."},{"issue":"1","key":"i1543-2165-135-4-483-b36","series-title":"J Clin Investig","first-page":"424","article-title":"Interleukin-10 prevents spontaneous death of germinal center B cells by induction of the bcl-2 protein","volume":"93","author":"Levy\n              Y,","year":"1994","unstructured":"Levy\n              Y, \n            \n              Brouet\n              JC. \n          \n          Interleukin-10 prevents spontaneous death of germinal center B cells by induction of the bcl-2 protein. J Clin Investig. 1994;93(1):424\u2013428."},{"issue":"3","key":"i1543-2165-135-4-483-b37","series-title":"Ann Hematol","first-page":"110","article-title":"Poor clinical outcome of patients with Hodgkin's disease and elevated interleukin-10 serum levels: clinical significance of interleukin-10 serum levels for Hodgkin's disease","volume":"79","author":"Bohlen\n              H,","year":"2000","unstructured":"Bohlen\n              H, \n            \n              Kessler\n              M, \n            \n              Sextro\n              M, \n            \n              Diehl\n              V, \n            \n              Tesch\n              H. \n          \n          Poor clinical outcome of patients with Hodgkin's disease and elevated interleukin-10 serum levels: clinical significance of interleukin-10 serum levels for Hodgkin's disease. Ann Hematol. 2000;79(3):110\u2013113."},{"issue":"1","key":"i1543-2165-135-4-483-b38","series-title":"Med Oncol","first-page":"59","article-title":"Elevated pretreatment serum of IL-10 are associated with poor prognosis in Hodgkin's disease, the Milan Cancer Institute experience","volume":"17","author":"Viviani\n              S,","year":"2000","unstructured":"Viviani\n              S, \n            \n              Notti\n              P, \n            \n              Bonfante\n              V, \n            \n              Verderio\n              P, \n            \n              Valagussa\n              P, \n            \n              Bonddonna\n              G. \n          \n          Elevated pretreatment serum of IL-10 are associated with poor prognosis in Hodgkin's disease, the Milan Cancer Institute experience. Med Oncol. 2000;17(1):59\u201363."},{"issue":"11","key":"i1543-2165-135-4-483-b39","series-title":"Leuk Lymphoma","first-page":"2091","article-title":"Elevated pretreatment interleukin-10 serum level is an International Prognostic Score (IPS)\u2013independent risk factor for early treatment failure in advanced stage Hodgkin lymphoma","volume":"49","author":"Rautert\n              R,","year":"2008","unstructured":"Rautert\n              R, \n            \n              Schinkothe\n              T, \n            \n              Franklin\n              J, \n            et al\n          . Elevated pretreatment interleukin-10 serum level is an International Prognostic Score (IPS)\u2013independent risk factor for early treatment failure in advanced stage Hodgkin lymphoma. Leuk Lymphoma. 2008;49(11):2091\u20132098."},{"issue":"12","key":"i1543-2165-135-4-483-b40","series-title":"J Exp Med","first-page":"1939","article-title":"Interleukin 13 is secreted by and stimulates the growth of Reed-Sternberg cells","volume":"189","author":"Kapp\n              U,","year":"1999","unstructured":"Kapp\n              U, \n            \n              Yeh\n              WC, \n            \n              Patterson\n              B, \n            et al\n          . Interleukin 13 is secreted by and stimulates the growth of Reed-Sternberg cells. J Exp Med. 1999;189(12):1939\u20131946."},{"issue":"4","key":"i1543-2165-135-4-483-b41","series-title":"Histopathology","first-page":"368","article-title":"Interleukin-13 and interleukin-13 receptor in Hodgkin's disease: possible autocrine mechanism and involvement in fibrosis","volume":"38","author":"Ohshima\n              K,","year":"2001","unstructured":"Ohshima\n              K, \n            \n              Akaiwa\n              M, \n            \n              Umeshita\n              R, \n            \n              Suzumiya\n              J, \n            \n              Izuhara\n              K, \n            \n              Kikuchi\n              M. \n          \n          Interleukin-13 and interleukin-13 receptor in Hodgkin's disease: possible autocrine mechanism and involvement in fibrosis. Histopathology. 2001;38(4):368\u2013375."},{"issue":"1","key":"i1543-2165-135-4-483-b42","series-title":"Blood","first-page":"250","article-title":"Interleukin 13 and interleukin 13 receptor are frequently expressed by Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma","volume":"97","author":"Skinnider\n              BF,","year":"2001","unstructured":"Skinnider\n              BF, \n            \n              Elia\n              AJ, \n            \n              Gascoyne\n              RD, \n            et al\n          . Interleukin 13 and interleukin 13 receptor are frequently expressed by Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma. Blood. 2001;97(1):250\u2013255."},{"issue":"13","key":"i1543-2165-135-4-483-b43","series-title":"J Clin Oncol","first-page":"1732","article-title":"Plasma Cytokine and soluble receptor signature predicts outcome of patients with classical Hodgkin's lymphoma: a study from the Groupe d'Etude des Lymphomes de l'Adulte","volume":"25","author":"Casasnovas\n              RO,","year":"2007","unstructured":"Casasnovas\n              RO, \n            \n              Mounier\n              N, \n            \n              Brice\n              P, \n            et al\n          . Plasma Cytokine and soluble receptor signature predicts outcome of patients with classical Hodgkin's lymphoma: a study from the Groupe d'Etude des Lymphomes de l'Adulte. J Clin Oncol. 2007;25(13):1732\u20131740."},{"issue":"11","key":"i1543-2165-135-4-483-b44","series-title":"J Clin Oncol","first-page":"1630","article-title":"Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting","volume":"7","author":"Lister\n              TA,","year":"1989","unstructured":"Lister\n              TA, \n            \n              Crowther\n              D, \n            \n              Sutcliffe\n              SB, \n            et al\n          . Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting. J Clin Oncol. 1989;7(11):1630\u20131636."},{"issue":"2","key":"i1543-2165-135-4-483-b45","series-title":"Am J Clin Pathol","first-page":"284","article-title":"Human papillomavirus and Epstein-Barr virus infection, p53 expression, and cellular proliferation in laryngeal carcinoma","volume":"126","author":"de Oliveira\n              DE,","year":"2006","unstructured":"de Oliveira\n              DE, \n            \n              Bacchi\n              MM, \n            \n              Macarenco\n              RS, \n            \n              Tagliarini\n              JV, \n            \n              Cordeiro\n              RC, \n            \n              Bacchi\n              CE. \n          \n          Human papillomavirus and Epstein-Barr virus infection, p53 expression, and cellular proliferation in laryngeal carcinoma. Am J Clin Pathol. 2006;126(2):284\u2013293."},{"issue":"5","key":"i1543-2165-135-4-483-b46","series-title":"Hematol Oncol Clin North Am","first-page":"805","article-title":"The potential role of innate immunity in the pathogenesis of Hodgkin's lymphoma","volume":"21","author":"Enblad\n              G,","year":"2007","unstructured":"Enblad\n              G, \n            \n              Molin\n              D, \n            \n              Glimelius\n              I, \n            \n              Fisher\n              M, \n            \n              Nilsson\n              G. \n          \n          The potential role of innate immunity in the pathogenesis of Hodgkin's lymphoma. Hematol Oncol Clin North Am. 2007;21(5):805\u2013823."},{"issue":"6","key":"i1543-2165-135-4-483-b47","series-title":"J Immunol","first-page":"3463","article-title":"Directing transition from innate to acquired immunity: defining a role for IL-6","volume":"175","author":"Jones\n              AS.","year":"2005","unstructured":"Jones\n              AS. \n          \n          Directing transition from innate to acquired immunity: defining a role for IL-6. J Immunol. 2005;175(6):3463\u20133468."},{"issue":"2","key":"i1543-2165-135-4-483-b48","series-title":"J Leukoc Biol","first-page":"227","article-title":"Interleukin-6 biology is coordinated by membrane-bound and soluble receptors: role in inflammation and cancer","volume":"80","author":"Rose-John\n              S,","year":"2006","unstructured":"Rose-John\n              S, \n            \n              Scheller\n              J, \n            \n              Elson\n              G, \n            \n              Jones\n              SA. \n          \n          Interleukin-6 biology is coordinated by membrane-bound and soluble receptors: role in inflammation and cancer. J Leukoc Biol. 2006;80(2):227\u2013236."},{"issue":"6","key":"i1543-2165-135-4-483-b49","series-title":"Hematol Oncol","first-page":"307","article-title":"Increased levels of circulating interleukin-6 in patients with Hodgkin's disease","volume":"9","author":"Gause\n              A,","year":"1991","unstructured":"Gause\n              A, \n            \n              Scholz\n              R, \n            \n              Klein\n              S, \n            et al\n          . Increased levels of circulating interleukin-6 in patients with Hodgkin's disease. Hematol Oncol. 1991;9(6):307\u2013313."},{"issue":"6","key":"i1543-2165-135-4-483-b50","series-title":"Cytokine","first-page":"251","article-title":"Cancer cachexia is mediated in part by the induction of IL-6\u2013like cytokines from the spleen","volume":"16","author":"Barton\n              BE,","year":"2001","unstructured":"Barton\n              BE, \n            \n              Murphy\n              TF. \n          \n          Cancer cachexia is mediated in part by the induction of IL-6\u2013like cytokines from the spleen. Cytokine. 2001;16(6):251\u2013257."},{"issue":"1","key":"i1543-2165-135-4-483-b51","series-title":"Clin Immunol Immunopathol","first-page":"16","article-title":"IL-6: insights into novel biological activities","volume":"85","author":"Barton\n              BE.","year":"1997","unstructured":"Barton\n              BE. \n          \n          IL-6: insights into novel biological activities. Clin Immunol Immunopathol. 1997;85(1):16\u201320."},{"issue":"9","key":"i1543-2165-135-4-483-b52","series-title":"Blood","first-page":"2877","article-title":"Interleukin-13 levels in serum from patients with Hodgkin disease and healthy volunteers","volume":"98","author":"Fiumara\n              P,","year":"2001","unstructured":"Fiumara\n              P, \n            \n              Cabanillas\n              F, \n            \n              Younes\n              A. \n          \n          Interleukin-13 levels in serum from patients with Hodgkin disease and healthy volunteers. Blood. 2001;98(9):2877\u20132878."}],"container-title":["Archives of Pathology &amp; Laboratory Medicine"],"original-title":[],"link":[{"URL":"https:\/\/aplm.kglmeridian.com\/view\/journals\/arpa\/135\/4\/article-p483.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/meridian.allenpress.com\/aplm\/article-pdf\/135\/4\/483\/2770852\/2010-0060-oa_1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aplm.kglmeridian.com\/downloadpdf\/journals\/arpa\/135\/4\/article-p483.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aplm.kglmeridian.com\/downloadpdf\/journals\/arpa\/135\/4\/article-p483.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T01:13:18Z","timestamp":1770772398000},"score":1,"resource":{"primary":{"URL":"https:\/\/aplm.kglmeridian.com\/view\/journals\/arpa\/135\/4\/article-p483.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4]]},"references-count":104,"journal-issue":{"issue":"4"},"URL":"https:\/\/doi.org\/10.5858\/2010-0060-oa.1","relation":{},"ISSN":["0003-9985","1543-2165"],"issn-type":[{"value":"0003-9985","type":"print"},{"value":"1543-2165","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,4]]}}}